Daratumumab Open label, dose-escalation safety study in Combination with Bortezomib and Dexamethasone in Patients with multiple myeloma

Update Il y a 4 ans
Reference: EUCTR2011-005692-16

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To establish the safety profile of daratumumab when given in combination with bortezomib and dexamethasone in subjects with relapsed or refractory MM


Inclusion criteria

  • Relapsed or Relapsed and Refractory Multiple myeloma